(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
Zanubrutinib
Obinutuzumab
Cancer.gov
NCCN Guidelines for Patients
ASH: COVID-19 Resources for Managing Blood Cancers
CLL Society